We are here to shine a light on critical diseases
Detalo measures blood volume, plasma volume and red blood cell volume in humans.
Treatment of heart failure and kidney diseases rely on an estimate of blood volume.
Detalo Measures Blood Volume in Humans
Detalo automatically determines total blood volume, red blood cell volume and plasma volume in humans in a rapid, safe and precise manner.
The Detalo Performance is to be used for athletes and science and is available for purchase today. The Detalo Clinical is currently going through the medical certification procedures and should be available for clinical use in 2020.
Spotlight on Blood Volume in Cardiovascular Diseases
2018 research from Dr. Strobeck et al. published in Journal of American College of Cardiology, indicates that blood volume guided treatment of cardiovascular diseases can reduce mortality and readmissions significantly.
According to the study, decongestion strategies for hospitalized heart failure patient today are based on a clinical assessment of volume status which often proves to be inaccurate. The study indicates that a quantitative intravascular volume metric (blood volume measurement) can support better decision.
In the study, treatment adjustments were determined by the primary MD based upon the blood volume measurement and results were significant:
“Heart Failure Outcomes With Volume-Guided Management” by John E. Strobeck et. al, 2018 (link)
Read more in the section on blood volume guided treatment of cardiovascular disease.
Guidelines for use of blood volume guided treatment of heart failure already exists. Volume status is always of importance.
As many other from the Nordics we are obsessed by the coming and going of the sun. Shining a light into the dark is an integrated part of how we think.
CLINICAL EVIDENCE ON
BLOOD VOLUME GUIDED TREATMENT
All research referenced is scientific evidence published by recognised institutions.